Thursday, August 16, 2018

Oncogene - Table of Contents alert Volume 37 Issue 33

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
Diagenode's epigenetics services - get better data, faster

DNA, RNA, and chromatin — integrative epigenomics profiling

  • DNA methylation analysis via RRBS
  • ChIP-Seq for low inputs, histones, transcription factors, other chromatin-associated proteins
  • RNA-seq for small RNAs, mRNA, ncRNAs, whole transcriptome using a ligation-free technology to detect picogram quantities of RNA, including bioinformatics analysis
Utilize our epigenetics expertise. We provide all wet lab and bioinformatics services using proprietary protocols designed to get you superior results.

TABLE OF CONTENTS

Volume 37, Issue 33

In this issue
Article
Brief Communications
Correction
Also new
AOP

Article

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival

Andrew Baker, Debra Wyatt, Maurizio Bocchetta, Jun Li, Aleksandra Filipovic et al.

Oncogene 2018 37 :4489 - 4504; May 10, 2018; 10.1038/s41388-018-0251-y

Abstract | Full Text

GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90

Hui Guo, Lianmei Zhao, Bianhua Shi, Jiayu Bao, Dexian Zheng et al.

Oncogene 2018 37 :4505 - 4517; May 10, 2018; 10.1038/s41388-018-0266-4

Abstract | Full Text

MASTL overexpression promotes chromosome instability and metastasis in breast cancer

Samuel Rogers, Rachael A. McCloy, Benjamin L. Parker, David Gallego-Ortega, Andrew M. K. Law et al.

Oncogene 2018 37 :4518 - 4533; May 10, 2018; 10.1038/s41388-018-0295-z

Abstract | Full Text

Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development

Lu Dai, Luis Del Valle, Wendell Miley, Denise Whitby, Augusto C. Ochoa et al.

Oncogene 2018 37 :4534 - 4545; May 10, 2018; 10.1038/s41388-018-0282-4

Abstract | Full Text

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo

Aditya Parekh, Subhayan Das, Sheetal Parida, Chandan Kanta Das, Debabrata Dutta et al.

Oncogene 2018 37 :4546 - 4561; May 10, 2018; 10.1038/s41388-018-0272-6

Abstract | Full Text

Genome-wide profiling of microRNAs reveals novel insights into the interactions between H9N2 avian influenza virus and avian dendritic cells

Jian Lin, Jing Xia, Tian Zhang, Keyun Zhang & Qian Yang

Oncogene 2018 37 :4562 - 4580; May 10, 2018; 10.1038/s41388-018-0279-z

Abstract | Full Text

Proteomic profiling identifies key coactivators utilized by mutant ERa proteins as potential new therapeutic targets

Leah A. Gates, Guowei Gu, Yue Chen, Aarti D. Rohira, Jonathan T. Lei et al.

Oncogene 2018 37 :4581 - 4598; May 11, 2018; 10.1038/s41388-018-0284-2

Abstract | Full Text

Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer

Kyle Knickelbein, Jingshan Tong, Dongshi Chen, Yi-Jun Wang, Sandra Misale et al.

Oncogene 2018 37 :4599 - 4610; May 14, 2018; 10.1038/s41388-018-0289-x

Abstract | Full Text

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

Katrien Berns, Joseph J. Caumanns, E. Marielle Hijmans, Annemiek M. C. Gennissen, Tesa M. Severson et al.

Oncogene 2018 37 :4611 - 4625; May 15, 2018; 10.1038/s41388-018-0300-6

Abstract | Full Text

Brief Communications

Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma

Giulia Maurizi, Narendra Verma, Abhilash Gadi, Alka Mansukhani & Claudio Basilico

Oncogene 2018 37 :4626 - 4632; May 10, 2018; 10.1038/s41388-018-0292-2

Abstract | Full Text

Correction

Correction: eEF-2 kinase is a critical regulator of Warbrug effect through controlling PP2A-A synthesis

Y Cheng, X Ren, Y Yuan, Y Shan, L Li et al.

Oncogene 2018 37 :4633 - 4634; July 04, 2018; 10.1038/s41388-018-0322-0

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature
 

No comments: